IR-Med, Inc. financial data

Symbol
IRME on OTC
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 14 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -177% % -238%
Return On Equity 667% %
Return On Assets -868% % -165%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77,238,961 shares 9.2%
Common Stock, Shares, Outstanding 77,238,961 shares
Entity Public Float $24,408,708 USD -39%
Common Stock, Value, Issued $77,000 USD 10%
Weighted Average Number of Shares Outstanding, Basic 73,755,083 shares 4.9%
Weighted Average Number of Shares Outstanding, Diluted 73,755,083 shares 4.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $535,000 USD -57%
General and Administrative Expense $902,000 USD -42%
Operating Income (Loss) $1,464,000 USD 58%
Nonoperating Income (Expense) $913,000 USD -45750%
Net Income (Loss) Attributable to Parent $2,350,000 USD 32%
Earnings Per Share, Basic 0 USD/shares 40%
Earnings Per Share, Diluted 0 USD/shares 40%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $63,000 USD -92%
Accounts Receivable, after Allowance for Credit Loss, Current $27,000 USD -25%
Assets, Current $90,000 USD -89%
Property, Plant and Equipment, Net $29,000 USD -31%
Operating Lease, Right-of-Use Asset $45,000 USD 0%
Assets $175,000 USD -80%
Accounts Payable, Current $139,000 USD
Employee-related Liabilities, Current $26,000 USD
Accrued Liabilities, Current $147,000 USD
Liabilities, Current $774,000 USD
Operating Lease, Liability, Noncurrent $26,000 USD
Liabilities $800,000 USD 53%
Retained Earnings (Accumulated Deficit) $18,212,000 USD -15%
Stockholders' Equity Attributable to Parent $625,000 USD -272%
Liabilities and Equity $175,000 USD -80%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $110,000 USD 69%
Net Cash Provided by (Used in) Financing Activities $31,000 USD
Common Stock, Shares Authorized 600,000,000 shares 0%
Common Stock, Shares, Issued 77,238,961 shares 9.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $78,000 USD 78%
Deferred Tax Assets, Valuation Allowance $2,344,000 USD 12%
Deferred Tax Assets, Gross $2,344,000 USD 11%
Depreciation $3,000 USD -67%
Property, Plant and Equipment, Gross $93,000 USD 0%
Operating Lease, Liability, Current $16,000 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Deferred Tax Assets, Operating Loss Carryforwards $2,182,000 USD 30%
Additional Paid in Capital $17,510,000 USD 8.4%